AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
In this episode, we explore KarXT, a groundbreaking experimental antipsychotic that works through the cholinergic system rather than dopamine pathways. Could this novel approach revolutionize schizophrenia treatment by offering similar efficacy to current antipsychotics but without the motor side effects?
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.